Neogen Corp NEOG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEOG is a good fit for your portfolio.
News
-
Neogen® to Participate in the Piper Sandler 35th Annual Healthcare Conference
-
Neogen Announces First-Quarter 2024 Results
-
Neogen Announces First-Quarter Earnings Release Date
-
Neogen® Releases New Professional Pest Management Solution
-
Neogen® To Participate in 2023 Wells Fargo Healthcare Conference
-
Neogen® Wins Best Innovative Luminol-Based Substrate Award
Trading Information
- Previous Close Price
- $16.78
- Day Range
- $16.46–16.80
- 52-Week Range
- $14.37–24.10
- Bid/Ask
- $15.42 / $16.60
- Market Cap
- $3.59 Bil
- Volume/Avg
- 1.4 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 31.95
- Price/Sales
- 3.90
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,640
- Website
- https://www.neogen.com
Valuation
|
Metric
|
NEOG
|
|---|---|
Price/Earnings (Normalized) | 31.95 |
Price/Book Value | 1.14 |
Price/Sales | 3.90 |
Price/Cash Flow | 41.15 |
Price/Earnings
NEOG
Financial Strength
|
Metric
|
NEOG
|
|---|---|
Quick Ratio | 2.73 |
Current Ratio | 4.23 |
Interest Coverage | 0.58 |
Quick Ratio
NEOG
Profitability
|
Metric
|
NEOG
|
|---|---|
Return on Assets (Normalized) | 2.92% |
Return on Equity (Normalized) | 4.17% |
Return on Invested Capital (Normalized) | 5.33% |
Return on Assets
NEOG
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Dfzk | $187.7 Bil | |
DHR
| Danaher Corp | Sqsrc | $161.6 Bil | |
IDXX
| IDEXX Laboratories Inc | Rggnzn | $39.1 Bil | |
IQV
| IQVIA Holdings Inc | Qzywzck | $38.5 Bil | |
A
| Agilent Technologies Inc | Sdzs | $36.5 Bil | |
MTD
| Mettler-Toledo International Inc | Yhrccy | $23.5 Bil | |
ICLR
| Icon PLC | Nzgky | $22.0 Bil | |
LH
| Laboratory Corp of America Holdings | Ztvbnw | $18.0 Bil | |
WAT
| Waters Corp | Pnxt | $16.3 Bil | |
ILMN
| Illumina Inc | Pmcwr | $15.3 Bil |